Biotechnology
The Biotechnology industry has a total of 598 stocks, with a combined market cap of $1.12 trillion and total revenue of $105.29 billion.
Market Cap
1.12T
Revenue
105.29B
Profits
-41.33B
PE Ratio
n/a
Profit Margin
-39.25%
Dividend Yield
0.04%
598 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 120.50B | -0.62% | 696,679 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 76.69B | -0.49% | 442,610 | 14.25B |
| 3 | ARGX | argenx SE | 51.85B | -0.14% | 122,924 | 3.68B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 45.81B | -0.82% | 793,197 | 3.21B |
| 5 | ONC | BeOne Medicines AG | 38.76B | 0.09% | 210,017 | 4.97B |
| 6 | INSM | Insmed Incorporated | 33.66B | 1.25% | 877,580 | 447.02M |
| 7 | BNTX | BioNTech SE | 29.32B | 0.59% | 252,920 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 23.53B | 0.87% | 1,455,551 | 2.35B |
| 9 | GMAB | Genmab A/S | 20.16B | 1.00% | 669,219 | 3.85B |
| 10 | INCY | Incyte Corporation | 19.87B | 0.05% | 595,521 | 4.81B |
| 11 | RVMD | Revolution Medicines, Inc. | 19.05B | 1.25% | 1,325,309 | - |
| 12 | MRNA | Moderna, Inc. | 18.16B | 2.58% | 7,847,481 | 2.23B |
| 13 | ROIV | Roivant Sciences Ltd. | 15.31B | 0.50% | 1,923,221 | 20.33M |
| 14 | BBIO | BridgeBio Pharma, Inc. | 15.09B | 1.05% | 662,521 | 353.78M |
| 15 | ASND | Ascendis Pharma A/S | 13.70B | 0.32% | 383,395 | 758.59M |
| 16 | IONS | Ionis Pharmaceuticals, Inc. | 13.56B | 2.17% | 900,718 | 966.96M |
| 17 | SMMT | Summit Therapeutics Inc. | 11.81B | -2.11% | 1,706,290 | - |
| 18 | EXEL | Exelixis, Inc. | 11.45B | -0.26% | 1,049,514 | 2.29B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.22B | -0.47% | 128,029 | 740.64M |
| 20 | RNA | Avidity Biosciences, Inc. | 10.93B | 0.11% | 599,020 | 20.87M |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.81B | -0.69% | 810,440 | 3.09B |
| 22 | JAZZ | Jazz Pharmaceuticals plc | 9.94B | -1.14% | 330,173 | 4.16B |
| 23 | TECH | Bio-Techne Corporation | 9.90B | -3.07% | 1,330,956 | 1.22B |
| 24 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.61B | 4.62% | 854,201 | 829.45M |
| 25 | AXSM | Axsome Therapeutics, Inc. | 9.31B | -0.22% | 216,771 | 561.26M |
| 26 | ABVX | ABIVAX Société Anonyme | 8.97B | -0.28% | 729,391 | 6.23M |
| 27 | PRAX | Praxis Precision Medicines, Inc. | 8.68B | 0.93% | 261,773 | 7.46M |
| 28 | HALO | Halozyme Therapeutics, Inc. | 8.54B | -0.34% | 834,040 | 1.24B |
| 29 | KRYS | Krystal Biotech, Inc. | 8.10B | 2.36% | 106,070 | 373.16M |
| 30 | CYTK | Cytokinetics, Incorporated | 8.02B | 0.72% | 697,004 | 87.21M |
| 31 | NUVL | Nuvalent, Inc. | 7.89B | 1.36% | 269,245 | - |
| 32 | CAI | Caris Life Sciences, Inc. | 7.03B | -6.04% | 2,345,239 | 649.06M |
| 33 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.94B | 1.33% | 92,767 | 174.33M |
| 34 | PCVX | Vaxcyte, Inc. | 6.83B | 1.62% | 223,387 | - |
| 35 | BLTE | Belite Bio, Inc | 6.22B | 0.11% | 265,953 | - |
| 36 | MIRM | Mirum Pharmaceuticals, Inc. | 6.14B | 1.71% | 290,251 | 471.79M |
| 37 | PTCT | PTC Therapeutics, Inc. | 6.14B | 1.18% | 531,444 | 1.78B |
| 38 | GPCR | Structure Therapeutics Inc. | 6.01B | -2.37% | 489,009 | - |
| 39 | KYMR | Kymera Therapeutics, Inc. | 5.88B | 3.27% | 273,786 | 43.74M |
| 40 | IBRX | ImmunityBio, Inc. | 5.79B | -4.39% | 17,545,866 | 82.56M |
| 41 | COGT | Cogent Biosciences, Inc. | 5.73B | -1.80% | 432,678 | - |
| 42 | CRNX | Crinetics Pharmaceuticals, Inc. | 5.32B | 1.03% | 308,835 | 1.54M |
| 43 | IMVT | Immunovant, Inc. | 5.28B | - | 271,497 | - |
| 44 | CELC | Celcuity Inc. | 5.10B | -3.74% | 412,473 | - |
| 45 | CRSP | CRISPR Therapeutics AG | 5.07B | -0.91% | 903,075 | 38.34M |
| 46 | PTGX | Protagonist Therapeutics, Inc. | 4.91B | -3.99% | 274,310 | 209.22M |
| 47 | CORT | Corcept Therapeutics Incorporated | 4.80B | -0.48% | 661,249 | 741.17M |
| 48 | APGE | Apogee Therapeutics, Inc. | 4.68B | -1.91% | 608,131 | - |
| 49 | SRRK | Scholar Rock Holding Corporation | 4.59B | 4.36% | 580,063 | - |
| 50 | TGTX | TG Therapeutics, Inc. | 4.44B | 0.13% | 605,260 | 531.90M |
| 51 | FOLD | Amicus Therapeutics, Inc. | 4.42B | -0.04% | 3,116,388 | 598.70M |
| 52 | ACAD | ACADIA Pharmaceuticals Inc. | 4.35B | 0.27% | 457,088 | 1.05B |
| 53 | CGON | CG Oncology, Inc. | 4.32B | -0.50% | 304,230 | 2.17M |
| 54 | ADMA | ADMA Biologics, Inc. | 4.01B | 3.12% | 632,513 | 488.56M |
| 55 | ACLX | Arcellx, Inc. | 3.95B | 0.37% | 193,084 | 35.90M |
| 56 | LQDA | Liquidia Corporation | 3.78B | 3.70% | 2,229,730 | 69.22M |
| 57 | LGND | Ligand Pharmaceuticals Incorporated | 3.76B | 0.48% | 82,286 | 251.23M |
| 58 | TERN | Terns Pharmaceuticals, Inc. | 3.74B | 0.25% | 922,704 | - |
| 59 | NAMS | NewAmsterdam Pharma Company N.V. | 3.55B | -1.66% | 159,739 | 35.24M |
| 60 | CNTA | Centessa Pharmaceuticals plc | 3.55B | -3.61% | 692,539 | 15.00M |
| 61 | VKTX | Viking Therapeutics, Inc. | 3.44B | 0.16% | 1,039,473 | - |
| 62 | ALMS | Alumis Inc. | 3.36B | -2.63% | 643,875 | 22.12M |
| 63 | DNLI | Denali Therapeutics Inc. | 3.35B | 3.02% | 846,761 | - |
| 64 | LEGN | Legend Biotech Corporation | 3.31B | 0.28% | 1,380,097 | 909.05M |
| 65 | XENE | Xenon Pharmaceuticals Inc. | 3.21B | -1.10% | 384,369 | 7.50M |
| 66 | VERA | Vera Therapeutics, Inc. | 3.19B | -0.47% | 291,528 | - |
| 67 | VRDN | Viridian Therapeutics, Inc. | 3.18B | -0.80% | 454,736 | 70.79M |
| 68 | ERAS | Erasca, Inc. | 3.14B | 0.05% | 1,694,357 | - |
| 69 | ARQT | Arcutis Biotherapeutics, Inc. | 3.13B | 0.51% | 596,228 | 317.93M |
| 70 | EWTX | Edgewise Therapeutics, Inc. | 3.05B | 0.45% | 219,485 | - |
| 71 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.99B | 0.50% | 410,329 | 578.20M |
| 72 | IRON | Disc Medicine, Inc. | 2.95B | -2.34% | 191,207 | - |
| 73 | APLS | Apellis Pharmaceuticals, Inc. | 2.95B | 1.00% | 1,646,230 | 1.02B |
| 74 | DYN | Dyne Therapeutics, Inc. | 2.92B | 0.17% | 1,240,603 | - |
| 75 | BEAM | Beam Therapeutics Inc. | 2.89B | 1.00% | 935,619 | 55.70M |
| 76 | IDYA | IDEAYA Biosciences, Inc. | 2.86B | -3.12% | 391,620 | 214.83M |
| 77 | TVTX | Travere Therapeutics, Inc. | 2.84B | 4.89% | 985,331 | 435.83M |
| 78 | ADPT | Adaptive Biotechnologies Corporation | 2.79B | -1.14% | 692,062 | 252.75M |
| 79 | TARS | Tarsus Pharmaceuticals, Inc. | 2.77B | 1.51% | 259,977 | 366.10M |
| 80 | IMNM | Immunome, Inc. | 2.76B | 1.09% | 564,624 | 9.68M |
| 81 | RCUS | Arcus Biosciences, Inc. | 2.69B | 0.25% | 380,301 | 240.00M |
| 82 | TLX | Telix Pharmaceuticals Limited | 2.62B | -4.57% | 141,135 | 664.23M |
| 83 | SYRE | Spyre Therapeutics, Inc. | 2.59B | 0.78% | 249,033 | - |
| 84 | MLYS | Mineralys Therapeutics, Inc. | 2.51B | -1.79% | 270,556 | - |
| 85 | WVE | Wave Life Sciences Ltd. | 2.36B | 1.34% | 932,491 | 109.23M |
| 86 | MESO | Mesoblast Limited | 2.33B | -4.55% | 138,311 | 17.20M |
| 87 | RARE | Ultragenyx Pharmaceutical Inc. | 2.32B | -1.35% | 796,105 | 630.60M |
| 88 | AAPG | Ascentage Pharma Group International | 2.31B | 0.20% | 939 | 54.52M |
| 89 | DNTH | Dianthus Therapeutics, Inc. | 2.27B | 4.87% | 556,346 | 3.08M |
| 90 | RXRX | Recursion Pharmaceuticals, Inc. | 2.27B | -2.46% | 12,785,630 | 43.69M |
| 91 | GLPG | Galapagos NV | 2.25B | 0.02% | 39,171 | 336.64M |
| 92 | SRPT | Sarepta Therapeutics, Inc. | 2.20B | -1.45% | 1,169,493 | 2.41B |
| 93 | SLNO | Soleno Therapeutics, Inc. | 2.20B | -1.66% | 966,312 | 98.68M |
| 94 | MAZE | Maze Therapeutics, Inc. | 2.14B | 2.44% | 187,071 | 2.50M |
| 95 | OCUL | Ocular Therapeutix, Inc. | 2.13B | -2.82% | 2,588,983 | 55.78M |
| 96 | HRMY | Harmony Biosciences Holdings, Inc. | 2.12B | -0.11% | 201,007 | 825.94M |
| 97 | OLMA | Olema Pharmaceuticals, Inc. | 2.04B | 5.49% | 908,625 | - |
| 98 | AUPH | Aurinia Pharmaceuticals Inc. | 1.93B | 0.48% | 299,608 | 265.81M |
| 99 | ZLAB | Zai Lab Limited | 1.92B | 0.23% | 284,774 | 441.63M |
| 100 | ARDX | Ardelyx, Inc. | 1.89B | -0.83% | 1,277,757 | 398.23M |
| 101 | SION | Sionna Therapeutics, Inc. | 1.87B | -0.57% | 130,026 | - |
| 102 | NUVB | Nuvation Bio Inc. | 1.83B | 0.57% | 2,734,922 | 26.75M |
| 103 | VCEL | Vericel Corporation | 1.82B | -0.61% | 126,971 | 258.72M |
| 104 | SNDX | Syndax Pharmaceuticals, Inc. | 1.81B | 1.22% | 336,554 | 111.30M |
| 105 | STOK | Stoke Therapeutics, Inc. | 1.79B | 6.63% | 227,826 | 205.63M |
| 106 | NRIX | Nurix Therapeutics, Inc. | 1.79B | -2.80% | 997,847 | 83.98M |
| 107 | PHVS | Pharvaris N.V. | 1.77B | -2.44% | 93,064 | - |
| 108 | MNKD | MannKind Corporation | 1.75B | 0.89% | 2,657,216 | 313.79M |
| 109 | CRVS | Corvus Pharmaceuticals, Inc. | 1.75B | 1.48% | 1,234,813 | - |
| 110 | ORKA | Oruka Therapeutics, Inc. | 1.70B | -0.20% | 178,118 | - |
| 111 | ZYME | Zymeworks Inc. | 1.68B | 0.87% | 281,650 | 134.48M |
| 112 | TYRA | Tyra Biosciences, Inc. | 1.68B | 1.25% | 133,674 | - |
| 113 | RAPT | RAPT Therapeutics, Inc. | 1.67B | - | 3,589,011 | - |
| 114 | DFTX | Definium Therapeutics, Inc. | 1.66B | -0.06% | 670,548 | - |
| 115 | GLUE | Monte Rosa Therapeutics, Inc. | 1.65B | -1.14% | 499,615 | 181.54M |
| 116 | UPB | Upstream Bio, Inc. | 1.65B | 0.59% | 295,287 | 2.80M |
| 117 | IMCR | Immunocore Holdings plc | 1.65B | -1.57% | 228,560 | 379.59M |
| 118 | NTLA | Intellia Therapeutics, Inc. | 1.65B | 2.82% | 3,405,174 | 57.53M |
| 119 | MBX | MBX Biosciences, Inc. | 1.64B | 1.87% | 150,882 | - |
| 120 | CLDX | Celldex Therapeutics, Inc. | 1.63B | -0.81% | 152,028 | 2.60M |
| 121 | OCS | Oculis Holding AG | 1.62B | -1.25% | 183,038 | 992.00K |
| 122 | PGEN | Precigen, Inc. | 1.62B | 2.47% | 1,480,361 | 6.31M |
| 123 | AGIO | Agios Pharmaceuticals, Inc. | 1.61B | -2.58% | 264,833 | 44.79M |
| 124 | BHVN | Biohaven Ltd. | 1.61B | -0.66% | 904,958 | - |
| 125 | FTRE | Fortrea Holdings Inc. | 1.56B | 1.02% | 419,086 | 2.76B |
| 126 | KOD | Kodiak Sciences Inc. | 1.56B | -3.68% | 217,819 | - |
| 127 | TNGX | Tango Therapeutics, Inc. | 1.55B | 2.86% | 564,730 | 66.50M |
| 128 | NVAX | Novavax, Inc. | 1.54B | 2.98% | 3,319,273 | 1.06B |
| 129 | ELVN | Enliven Therapeutics, Inc. | 1.51B | -0.04% | 946,568 | - |
| 130 | INVA | Innoviva, Inc. | 1.48B | 0.92% | 221,112 | 388.52M |
| 131 | QURE | uniQure N.V. | 1.44B | 0.39% | 307,614 | 15.75M |
| 132 | PHAR | Pharming Group N.V. | 1.41B | 0.29% | 24,544 | 362.27M |
| 133 | ATAI | AtaiBeckley Inc. | 1.39B | -0.78% | 2,165,176 | 3.02M |
| 134 | DBVT | DBV Technologies S.A. | 1.39B | -0.93% | 303,144 | 5.50M |
| 135 | TRVI | Trevi Therapeutics, Inc. | 1.35B | -0.10% | 706,619 | - |
| 136 | RLAY | Relay Therapeutics, Inc. | 1.34B | 1.44% | 698,817 | 8.36M |
| 137 | SVRA | Savara Inc. | 1.34B | -0.89% | 539,344 | - |
| 138 | ANAB | AnaptysBio, Inc. | 1.32B | 0.40% | 161,932 | 169.47M |
| 139 | IVA | Inventiva S.A. | 1.30B | -7.17% | 345,062 | 19.93M |
| 140 | RAPP | Rapport Therapeutics, Inc. | 1.28B | 1.44% | 68,987 | - |
| 141 | IMTX | Immatics N.V. | 1.26B | -3.40% | 175,901 | 99.45M |
| 142 | TSHA | Taysha Gene Therapies, Inc. | 1.24B | 0.78% | 831,972 | 6.31M |
| 143 | SANA | Sana Biotechnology, Inc. | 1.23B | -2.74% | 1,055,492 | - |
| 144 | EYPT | EyePoint, Inc. | 1.22B | -1.80% | 313,813 | 42.34M |
| 145 | XERS | Xeris Biopharma Holdings, Inc. | 1.19B | 0.14% | 629,722 | 266.14M |
| 146 | DAWN | Day One Biopharmaceuticals, Inc. | 1.17B | -3.31% | 1,625,283 | 133.67M |
| 147 | CAPR | Capricor Therapeutics, Inc. | 1.17B | 4.59% | 732,346 | 11.13M |
| 148 | ABCL | AbCellera Biologics Inc. | 1.16B | -1.03% | 1,882,167 | 35.33M |
| 149 | MLTX | MoonLake Immunotherapeutics | 1.15B | -0.74% | 665,482 | - |
| 150 | CMPX | Compass Therapeutics, Inc. | 1.12B | 2.35% | 1,962,356 | 850.00K |
| 151 | ZBIO | Zenas BioPharma, Inc. | 1.11B | -3.91% | 320,907 | 15.00M |
| 152 | SEPN | Septerna, Inc. | 1.08B | 2.11% | 125,561 | 22.05M |
| 153 | INBX | Inhibrx Biosciences, Inc. | 1.08B | 0.46% | 140,623 | 1.40M |
| 154 | VIR | Vir Biotechnology, Inc. | 1.08B | 2.25% | 496,090 | 16.86M |
| 155 | PHAT | Phathom Pharmaceuticals, Inc. | 1.07B | -0.87% | 210,731 | 147.19M |
| 156 | IOVA | Iovance Biotherapeutics, Inc. | 1.07B | -2.36% | 7,354,880 | 250.43M |
| 157 | ORIC | ORIC Pharmaceuticals, Inc. | 1.04B | -2.46% | 1,155,457 | - |
| 158 | AKTS | Aktis Oncology, Inc. | 1.04B | -3.51% | 253,957 | 5.56M |
| 159 | NBTX | Nanobiotix S.A. | 1.04B | -3.81% | 5,222 | 11.93M |
| 160 | SPRY | ARS Pharmaceuticals, Inc. | 1.02B | 2.09% | 1,507,364 | 142.77M |
| 161 | GHRS | GH Research PLC | 1.01B | 1.09% | 67,005 | - |
| 162 | VTYX | Ventyx Biosciences, Inc. | 1.00B | -0.04% | 621,396 | - |
| 163 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 999.46M | -3.74% | 153,658 | - |
| 164 | CTMX | CytomX Therapeutics, Inc. | 975.95M | -2.37% | 1,003,763 | 113.63M |
| 165 | URGN | UroGen Pharma Ltd. | 970.35M | -2.77% | 243,046 | 96.52M |
| 166 | TBPH | Theravance Biopharma, Inc. | 968.35M | 0.42% | 118,044 | 80.33M |
| 167 | ANNX | Annexon, Inc. | 961.41M | 2.54% | 675,668 | - |
| 168 | PVLA | Palvella Therapeutics, Inc. | 955.91M | 2.60% | 94,766 | - |
| 169 | AVBP | ArriVent BioPharma, Inc. | 929.04M | -0.29% | 90,023 | - |
| 170 | BCAX | Bicara Therapeutics Inc. | 924.99M | 1.78% | 160,924 | - |
| 171 | XNCR | Xencor, Inc. | 894.42M | 1.42% | 162,618 | 150.13M |
| 172 | MRVI | Maravai LifeSciences Holdings, Inc. | 891.14M | 1.90% | 523,129 | 192.44M |
| 173 | GERN | Geron Corporation | 871.35M | 2.63% | 10,196,283 | 183.40M |
| 174 | OMER | Omeros Corporation | 856.48M | 2.29% | 516,337 | - |
| 175 | ARVN | Arvinas, Inc. | 850.97M | 2.47% | 427,757 | 312.30M |
| 176 | JANX | Janux Therapeutics, Inc. | 830.64M | -1.00% | 448,118 | 10.00M |
| 177 | VALN | Valneva SE | 824.86M | -0.28% | 6,427 | 211.09M |
| 178 | MPLT | MapLight Therapeutics, Inc. | 813.04M | -1.22% | 133,463 | - |
| 179 | ABUS | Arbutus Biopharma Corporation | 791.41M | -0.60% | 342,292 | 14.61M |
| 180 | DRUG | Bright Minds Biosciences Inc. | 790.63M | 2.08% | 58,039 | - |
| 181 | KALV | KalVista Pharmaceuticals, Inc. | 785.99M | 2.71% | 411,595 | 1.43M |
| 182 | YDES | YD Bio Limited | 781.25M | -9.23% | 56,390 | 510.36K |
| 183 | MDXG | MiMedx Group, Inc. | 753.10M | -1.26% | 332,598 | 393.44M |
| 184 | PRME | Prime Medicine, Inc. | 732.94M | 2.73% | 1,784,425 | 5.98M |
| 185 | GYRE | Gyre Therapeutics, Inc. | 721.67M | -1.12% | 56,815 | 107.27M |
| 186 | NKTR | Nektar Therapeutics | 718.26M | -1.67% | 299,133 | 62.60M |
| 187 | KURA | Kura Oncology, Inc. | 713.54M | 1.99% | 357,333 | 104.03M |
| 188 | EVMN | Evommune, Inc. | 704.56M | 9.08% | 301,671 | 13.00M |
| 189 | CGEM | Cullinan Therapeutics, Inc. | 700.64M | 0.08% | 202,915 | - |
| 190 | FULC | Fulcrum Therapeutics, Inc. | 698.63M | 1.05% | 200,755 | 80.00M |
| 191 | JBIO | Jade Biosciences, Inc. | 695.81M | -3.29% | 79,814 | - |
| 192 | SLS | SELLAS Life Sciences Group, Inc. | 681.13M | 0.88% | 4,772,794 | - |
| 193 | ENGN | enGene Holdings Inc. | 676.55M | -0.98% | 73,182 | - |
| 194 | RIGL | Rigel Pharmaceuticals, Inc. | 639.65M | -0.03% | 199,267 | 282.08M |
| 195 | PROK | ProKidney Corp. | 636.26M | 0.71% | 595,568 | 744.00K |
| 196 | CRMD | CorMedix Inc. | 629.52M | 3.10% | 1,730,121 | 214.30M |
| 197 | MGTX | MeiraGTx Holdings plc | 623.00M | -0.26% | 178,286 | 27.42M |
| 198 | DRTS | Alpha Tau Medical Ltd. | 607.08M | -6.32% | 444,043 | - |
| 199 | DSGN | Design Therapeutics, Inc. | 590.14M | 2.27% | 121,863 | - |
| 200 | RGNX | REGENXBIO Inc. | 584.70M | 4.90% | 757,195 | 161.32M |
| 201 | REPL | Replimune Group, Inc. | 576.56M | -0.14% | 324,706 | - |
| 202 | GOSS | Gossamer Bio, Inc. | 565.91M | -4.12% | 2,791,318 | 44.05M |
| 203 | ALT | Altimmune, Inc. | 562.69M | 0.68% | 2,991,394 | 20.00K |
| 204 | KROS | Keros Therapeutics, Inc. | 547.17M | 0.73% | 94,090 | 246.72M |
| 205 | TENX | Tenax Therapeutics, Inc. | 544.05M | -4.28% | 137,043 | - |
| 206 | LXEO | Lexeo Therapeutics, Inc. | 536.09M | -1.28% | 172,209 | - |
| 207 | VOR | Vor Biopharma Inc. | 535.11M | 0.58% | 332,900 | - |
| 208 | LENZ | LENZ Therapeutics, Inc. | 534.75M | -8.36% | 915,770 | 17.50M |
| 209 | LBRX | LB Pharmaceuticals Inc | 533.18M | -0.78% | 51,094 | - |
| 210 | DNA | Ginkgo Bioworks Holdings, Inc. | 522.89M | -2.44% | 371,969 | 180.61M |
| 211 | IVVD | Invivyd, Inc. | 521.68M | -3.65% | 1,397,718 | 50.04M |
| 212 | LXRX | Lexicon Pharmaceuticals, Inc. | 521.48M | -4.33% | 1,015,761 | 70.86M |
| 213 | CTNM | Contineum Therapeutics, Inc. | 520.91M | -1.18% | 139,525 | - |
| 214 | FBRX | Forte Biosciences, Inc. | 516.49M | -2.96% | 86,824 | - |
| 215 | LYEL | Lyell Immunopharma, Inc. | 515.59M | 1.00% | 21,503 | 41.00K |
| 216 | FDMT | 4D Molecular Therapeutics, Inc. | 514.22M | 4.65% | 402,678 | 120.00K |
| 217 | SLDB | Solid Biosciences Inc. | 511.09M | 0.15% | 287,141 | - |
| 218 | OCGN | Ocugen, Inc. | 496.75M | -1.62% | 2,092,857 | 5.37M |
| 219 | ZVRA | Zevra Therapeutics, Inc. | 493.73M | 1.62% | 332,563 | 84.39M |
| 220 | VSTM | Verastem, Inc. | 485.47M | 0.96% | 672,679 | 13.38M |
| 221 | PRTA | Prothena Corporation plc | 483.93M | -1.64% | 174,545 | 11.79M |
| 222 | NAGE | Niagen Bioscience, Inc. | 477.73M | -1.08% | 390,128 | 124.71M |
| 223 | ANRO | Alto Neuroscience, Inc. | 473.76M | -0.52% | 204,235 | - |
| 224 | KYTX | Kyverna Therapeutics, Inc. | 471.89M | -1.43% | 511,556 | - |
| 225 | VNDA | Vanda Pharmaceuticals Inc. | 464.50M | 2.21% | 396,834 | 212.07M |
| 226 | ABSI | Absci Corporation | 460.89M | 4.25% | 2,915,263 | 2.82M |
| 227 | ADCT | ADC Therapeutics SA | 456.49M | 4.10% | 345,714 | 75.21M |
| 228 | BCYC | Bicycle Therapeutics plc | 452.97M | -0.76% | 122,943 | 28.34M |
| 229 | PRTC | PureTech Health plc | 449.40M | -4.25% | 23 | 6.39M |
| 230 | DMAC | DiaMedica Therapeutics Inc. | 448.45M | -0.83% | 110,578 | - |
| 231 | MNPR | Monopar Therapeutics Inc. | 447.27M | -0.75% | 233,588 | - |
| 232 | IMMP | Immutep Limited | 443.43M | -3.27% | 173,368 | 3.31M |
| 233 | EPRX | Eupraxia Pharmaceuticals Inc. | 437.95M | -2.93% | 14,958 | - |
| 234 | NBP | NovaBridge Biosciences | 435.80M | -2.33% | 406,410 | - |
| 235 | AVXL | Anavex Life Sciences Corp. | 428.87M | -1.44% | 372,683 | - |
| 236 | BNTC | Benitec Biopharma Inc. | 426.33M | 4.22% | 68,333 | - |
| 237 | VTVT | vTv Therapeutics Inc. | 418.30M | -0.97% | 3,083 | 17.00K |
| 238 | TRDA | Entrada Therapeutics, Inc. | 417.43M | 4.39% | 74,900 | 61.52M |
| 239 | GLSI | Greenwich LifeSciences, Inc. | 414.67M | 4.69% | 239,964 | - |
| 240 | ASMB | Assembly Biosciences, Inc. | 399.70M | -4.35% | 52,407 | 37.19M |
| 241 | ZURA | Zura Bio Limited | 384.94M | -1.00% | 216,056 | - |
| 242 | AUTL | Autolus Therapeutics plc | 384.58M | -0.34% | 627,689 | 51.13M |
| 243 | RCKT | Rocket Pharmaceuticals, Inc. | 384.19M | -0.84% | 633,464 | - |
| 244 | LCTX | Lineage Cell Therapeutics, Inc. | 381.67M | -0.32% | 719,222 | 10.82M |
| 245 | TECX | Tectonic Therapeutic, Inc. | 379.38M | 2.43% | 119,738 | - |
| 246 | ACRS | Aclaris Therapeutics, Inc. | 373.25M | -1.85% | 374,715 | 15.74M |
| 247 | ENTA | Enanta Pharmaceuticals, Inc. | 370.02M | 1.34% | 60,893 | 65.32M |
| 248 | TARA | Protara Therapeutics, Inc. | 368.68M | -4.04% | 628,771 | - |
| 249 | PEPG | PepGen Inc. | 354.05M | -1.34% | 372,801 | - |
| 250 | AURA | Aura Biosciences, Inc. | 347.68M | 1.01% | 84,389 | - |
| 251 | NMRA | Neumora Therapeutics, Inc. | 341.58M | -1.47% | 418,856 | - |
| 252 | HELP | Cybin Inc. | 341.34M | -4.07% | 268,212 | - |
| 253 | ALLO | Allogene Therapeutics, Inc. | 339.34M | 4.14% | 5,304,229 | 22.00K |
| 254 | ACIU | AC Immune SA | 338.39M | -1.44% | 115,525 | 5.48M |
| 255 | FHTX | Foghorn Therapeutics Inc. | 338.02M | -1.70% | 28,666 | 24.52M |
| 256 | PBYI | Puma Biotechnology, Inc. | 323.51M | 1.58% | 182,754 | 212.00M |
| 257 | ALDX | Aldeyra Therapeutics, Inc. | 321.87M | -1.29% | 312,062 | - |
| 258 | CADL | Candel Therapeutics, Inc. | 321.70M | 2.09% | 300,266 | - |
| 259 | XFOR | X4 Pharmaceuticals, Inc. | 316.76M | 0.07% | 104,035 | 33.98M |
| 260 | IMRX | Immuneering Corporation | 315.10M | -2.40% | 572,631 | - |
| 261 | IMMX | Immix Biopharma, Inc. | 311.96M | -3.58% | 682,436 | - |
| 262 | LRMR | Larimar Therapeutics, Inc. | 308.98M | -1.90% | 485,537 | - |
| 263 | AVIR | Atea Pharmaceuticals, Inc. | 303.13M | 0.26% | 232,061 | - |
| 264 | XOMA | XOMA Royalty Corporation | 301.53M | -1.26% | 140,880 | 47.11M |
| 265 | RZLT | Rezolute, Inc. | 301.36M | -3.85% | 1,398,265 | - |
| 266 | CLLS | Cellectis S.A. | 295.17M | -4.01% | 33,067 | 82.55M |
| 267 | NGNE | Neurogene Inc. | 290.59M | -2.65% | 60,642 | 925.00K |
| 268 | RLMD | Relmada Therapeutics, Inc. | 288.93M | -0.25% | 187,518 | - |
| 269 | AARD | Aardvark Therapeutics, Inc. | 288.50M | - | 81,507 | - |
| 270 | CHRS | Coherus Oncology, Inc. | 287.07M | 7.22% | 1,820,162 | 277.73M |
| 271 | AVTX | Avalo Therapeutics, Inc. | 280.56M | 1.24% | 102,352 | 192.00K |
| 272 | ABEO | Abeona Therapeutics Inc. | 277.19M | 5.90% | 1,343,636 | 400.00K |
| 273 | CABA | Cabaletta Bio, Inc. | 266.17M | -2.98% | 2,204,192 | - |
| 274 | OABI | OmniAb, Inc. | 263.45M | -1.08% | 234,373 | 21.09M |
| 275 | FENC | Fennec Pharmaceuticals Inc. | 257.86M | 1.21% | 57,102 | 38.79M |
| 276 | STTK | Shattuck Labs, Inc. | 254.38M | -3.60% | 344,586 | 1.00M |
| 277 | ENLV | Enlivex Therapeutics Ltd. | 251.62M | -7.83% | 346,192 | - |
| 278 | NAUT | Nautilus Biotechnology, Inc. | 245.03M | -5.83% | 112,643 | - |
| 279 | HRTX | Heron Therapeutics, Inc. | 244.79M | 0.38% | 663,795 | 155.10M |
| 280 | NBY | NovaBay Pharmaceuticals, Inc. | 239.73M | -5.00% | 979,300 | 10.30M |
| 281 | ARMP | Armata Pharmaceuticals, Inc. | 237.01M | 0.77% | 39,864 | 5.05M |
| 282 | PALI | Palisade Bio, Inc. | 236.92M | -4.79% | 4,562,918 | - |
| 283 | SLN | Silence Therapeutics plc | 234.28M | -1.00% | 98,932 | 25.83M |
| 284 | ACHV | Achieve Life Sciences, Inc. | 234.23M | 0.92% | 597,028 | - |
| 285 | CLYM | Climb Bio, Inc. | 231.08M | -6.20% | 368,690 | - |
| 286 | MDWD | MediWound Ltd. | 230.14M | -2.55% | 105,120 | 20.93M |
| 287 | CNTX | Context Therapeutics Inc. | 229.70M | 4.17% | 2,408,420 | - |
| 288 | TNXP | Tonix Pharmaceuticals Holding Corp. | 225.84M | -0.36% | 280,796 | 10.30M |
| 289 | VYGR | Voyager Therapeutics, Inc. | 219.62M | -0.50% | 324,709 | 31.32M |
| 290 | IKT | Inhibikase Therapeutics, Inc. | 215.43M | -0.94% | 183,027 | 1.00 |
| 291 | NVCT | Nuvectis Pharma, Inc. | 215.42M | 0.48% | 61,412 | - |
| 292 | ARCT | Arcturus Therapeutics Holdings Inc. | 215.38M | 2.85% | 282,587 | 97.60M |
| 293 | OBIO | Orchestra BioMed Holdings, Inc. | 211.18M | -4.83% | 248,809 | 2.82M |
| 294 | SABS | SAB Biotherapeutics, Inc. | 208.04M | -0.91% | 417,617 | 114.70K |
| 295 | ALEC | Alector, Inc. | 207.93M | -0.26% | 308,603 | 69.05M |
| 296 | EDIT | Editas Medicine, Inc. | 204.02M | 1.46% | 1,002,583 | 46.38M |
| 297 | CBIO | Crescent Biopharma, Inc. | 200.97M | -4.19% | 136,932 | - |
| 298 | CAMP | Camp4 Therapeutics Corporation | 200.00M | -3.63% | 27,039 | 3.80M |
| 299 | HUMA | Humacyte, Inc. | 198.79M | 3.00% | 1,960,518 | 1.57M |
| 300 | TLSA | Tiziana Life Sciences Ltd | 197.82M | -3.73% | 77,187 | - |
| 301 | OVID | Ovid Therapeutics Inc. | 195.93M | -2.90% | 970,161 | 6.61M |
| 302 | MIST | Milestone Pharmaceuticals Inc. | 193.01M | -2.06% | 2,186,843 | - |
| 303 | MENS | Jyong Biotech Ltd. | 190.33M | -2.17% | 390,788 | - |
| 304 | CCCC | C4 Therapeutics, Inc. | 188.98M | -3.94% | 688,688 | 30.11M |
| 305 | SRZN | Surrozen, Inc. | 188.36M | 1.34% | 45,528 | 3.60M |
| 306 | GALT | Galectin Therapeutics Inc. | 188.26M | -5.19% | 179,261 | - |
| 307 | ANL | Adlai Nortye Ltd. | 186.72M | 45.82% | 526,350 | -1.35M |
| 308 | NERV | Minerva Neurosciences, Inc. | 181.75M | 0.72% | 36,226 | - |
| 309 | THAR | Tharimmune, Inc. | 181.05M | 13.09% | 2,838,497 | - |
| 310 | RNAC | Cartesian Therapeutics, Inc. | 180.99M | -4.40% | 28,679 | 1.09M |
| 311 | CGEN | Compugen Ltd. | 180.06M | -1.28% | 130,890 | 6.90M |
| 312 | IPSC | Century Therapeutics, Inc. | 179.87M | -12.71% | 1,180,117 | 113.34M |
| 313 | IRD | Opus Genetics, Inc. | 177.24M | -4.81% | 580,666 | 14.63M |
| 314 | SLGL | Sol-Gel Technologies Ltd. | 176.98M | 0.05% | 12,875 | 18.97M |
| 315 | IPHA | Innate Pharma S.A. | 173.74M | 1.97% | 10,645 | 14.84M |
| 316 | NTHI | NeOnc Technologies Holdings, Inc. | 173.32M | -8.81% | 35,084 | 59.99K |
| 317 | KLRS | Kalaris Therapeutics, Inc. | 170.00M | -3.81% | 6,712 | - |
| 318 | SGMT | Sagimet Biosciences Inc. | 169.76M | -10.85% | 3,386,490 | - |
| 319 | NKTX | Nkarta, Inc. | 169.76M | -3.24% | 318,849 | - |
| 320 | SGMO | Sangamo Therapeutics, Inc. | 169.09M | 38.09% | 27,354,142 | 32.88M |
| 321 | TNYA | Tenaya Therapeutics, Inc. | 169.07M | 18.32% | 11,431,805 | - |
| 322 | PRQR | ProQR Therapeutics N.V. | 168.55M | -1.23% | 220,274 | 18.86M |
| 323 | ABOS | Acumen Pharmaceuticals, Inc. | 168.39M | -1.07% | 659,801 | - |
| 324 | ELDN | Eledon Pharmaceuticals, Inc. | 165.05M | -2.35% | 176,418 | - |
| 325 | PLX | Protalix BioTherapeutics, Inc. | 164.96M | -0.43% | 404,380 | 61.84M |
| 326 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 159.72M | -0.92% | 94,931 | - |
| 327 | ZNTL | Zentalis Pharmaceuticals, Inc. | 159.29M | -3.91% | 379,018 | 26.87M |
| 328 | MOLN | Molecular Partners AG | 157.11M | -0.12% | 5,683 | 856.30K |
| 329 | RANI | Rani Therapeutics Holdings, Inc. | 156.76M | -3.73% | 1,063,311 | 1.20M |
| 330 | QNCX | Quince Therapeutics, Inc. | 156.19M | -11.79% | 1,103,422 | - |
| 331 | BDTX | Black Diamond Therapeutics, Inc. | 150.41M | 2.72% | 394,783 | 70.00M |
| 332 | PRLD | Prelude Therapeutics Incorporated | 149.14M | -8.12% | 124,553 | 10.50M |
| 333 | VXRT | Vaxart, Inc. | 148.02M | -3.62% | 257,200 | 148.20M |
| 334 | CNTB | Connect Biopharma Holdings Limited | 142.55M | 2.82% | 12,383 | 762.00K |
| 335 | ELTX | Elicio Therapeutics, Inc. | 140.94M | -1.53% | 41,729 | - |
| 336 | UNCY | Unicycive Therapeutics, Inc. | 139.05M | -7.83% | 1,298,582 | - |
| 337 | CRBU | Caribou Biosciences, Inc. | 137.87M | -2.96% | 545,792 | 9.30M |
| 338 | FATE | Fate Therapeutics, Inc. | 137.85M | -1.24% | 499,792 | 7.14M |
| 339 | ORMP | Oramed Pharmaceuticals Inc. | 136.12M | -1.44% | 85,500 | 2.00M |
| 340 | MCRB | Seres Therapeutics, Inc. | 136.06M | -0.66% | 11,276 | 351.00K |
| 341 | TTRX | Turn Therapeutics Inc. | 128.68M | -4.38% | 17,403 | - |
| 342 | STRO | Sutro Biopharma, Inc. | 128.13M | -3.65% | 65,651 | 105.65M |
| 343 | SPRO | Spero Therapeutics, Inc. | 127.89M | 1.79% | 113,792 | 40.55M |
| 344 | KRRO | Korro Bio, Inc. | 125.25M | 13.77% | 955,874 | 7.37M |
| 345 | WHWK | Whitehawk Therapeutics, Inc. | 124.42M | -2.22% | 47,581 | 14.38M |
| 346 | KPTI | Karyopharm Therapeutics Inc. | 123.41M | -2.60% | 130,595 | 142.53M |
| 347 | ADAG | Adagene Inc. | 122.73M | -5.99% | 128,438 | 103.20K |
| 348 | MGNX | MacroGenics, Inc. | 120.19M | 5.56% | 679,808 | 127.63M |
| 349 | CDXS | Codexis, Inc. | 119.68M | 2.71% | 774,360 | 52.93M |
| 350 | GNLX | Genelux Corporation | 119.13M | -2.54% | 137,506 | 8.00K |
| 351 | ACOG | Alpha Cognition Inc. | 117.52M | 0.65% | 6,226 | 7.43M |
| 352 | VRCA | Verrica Pharmaceuticals Inc. | 115.29M | 0.42% | 59,500 | 30.83M |
| 353 | ONCY | Oncolytics Biotech Inc. | 114.06M | -4.50% | 508,565 | - |
| 354 | CRDF | Cardiff Oncology, Inc. | 111.14M | 1.85% | 2,501,543 | 501.00K |
| 355 | INO | Inovio Pharmaceuticals, Inc. | 110.61M | 5.23% | 1,450,359 | 182.34K |
| 356 | ACTU | Actuate Therapeutics, Inc. | 110.41M | -4.43% | 56,348 | - |
| 357 | CGTX | Cognition Therapeutics, Inc. | 109.46M | - | 555,491 | - |
| 358 | VANI | Vivani Medical, Inc. | 108.70M | - | 1,033,580 | - |
| 359 | ARTV | Artiva Biotherapeutics, Inc. | 106.28M | -3.13% | 111,155 | 251.00K |
| 360 | SEER | Seer, Inc. | 104.35M | -0.80% | 90,713 | 16.38M |
| 361 | FBIO | Fortress Biotech, Inc. | 104.13M | -0.74% | 233,965 | 62.30M |
| 362 | CSBR | Champions Oncology, Inc. | 102.55M | -3.08% | 2,793 | 58.42M |
| 363 | ANIX | Anixa Biosciences, Inc. | 101.80M | 0.66% | 157,150 | - |
| 364 | AGEN | Agenus Inc. | 101.51M | -4.02% | 673,280 | 106.83M |
| 365 | CBUS | Cibus, Inc. | 99.23M | 3.98% | 610,037 | 3.79M |
| 366 | SAVA | Cassava Sciences, Inc. | 98.79M | 0.25% | 454,677 | - |
| 367 | PYXS | Pyxis Oncology, Inc. | 96.51M | 2.65% | 188,299 | 2.82M |
| 368 | COYA | Coya Therapeutics, Inc. | 95.83M | -0.43% | 108,739 | 3.99M |
| 369 | DTIL | Precision BioSciences, Inc. | 94.72M | -0.63% | 95,535 | 698.00K |
| 370 | DWTX | Dogwood Therapeutics, Inc. | 92.40M | -6.19% | 40,020 | - |
| 371 | GUTS | Fractyl Health, Inc. | 91.24M | -67.49% | 79,856,187 | 3.00K |
| 372 | ETHZ | ETHZilla Corporation | 88.41M | -3.73% | 279,970 | 4.11M |
| 373 | MAIA | MAIA Biotechnology, Inc. | 87.63M | -17.63% | 2,237,049 | - |
| 374 | ALXO | ALX Oncology Holdings Inc. | 87.62M | 17.96% | 387,029 | - |
| 375 | MNOV | MediciNova, Inc. | 86.50M | -1.68% | 36,079 | 257.92K |
| 376 | SPRB | Spruce Biosciences, Inc. | 85.62M | -2.33% | 9,051 | 697.00K |
| 377 | EXOZ | eXoZymes, Inc. | 85.60M | -1.74% | 804 | -700.00 |
| 378 | ACET | Adicet Bio, Inc. | 84.44M | -1.12% | 20,859 | - |
| 379 | ATYR | aTyr Pharma, Inc. | 84.27M | 27.56% | 11,959,132 | 190.00K |
| 380 | HYFT | MindWalk Holdings Corp. | 84.04M | -10.45% | 577,007 | 19.02M |
| 381 | EQ | Equillium, Inc. | 83.42M | -2.14% | 370,172 | 4.39M |
| 382 | BMEA | Biomea Fusion, Inc. | 83.08M | -6.75% | 1,388,341 | - |
| 383 | IMA | ImageneBio, Inc. | 79.08M | 0.47% | 11,315 | 800.00K |
| 384 | PYPD | PolyPid Ltd. | 78.35M | -0.21% | 16,088 | - |
| 385 | XBIT | XBiotech Inc. | 78.05M | -3.03% | 22,080 | - |
| 386 | ATOS | Atossa Therapeutics, Inc. | 76.73M | -3.63% | 1,551,249 | - |
| 387 | OKYO | OKYO Pharma Limited | 76.35M | -7.31% | 265,520 | - |
| 388 | COEP | Coeptis Therapeutics Holdings, Inc. | 76.31M | -0.92% | 63,102 | 501.00K |
| 389 | PLRX | Pliant Therapeutics, Inc. | 76.20M | -0.80% | 617,289 | - |
| 390 | ANVS | Annovis Bio, Inc. | 75.80M | -5.92% | 384,287 | - |
| 391 | PTHS | Pelthos Therapeutics Inc. | 75.53M | -0.89% | 3,731 | 7.41M |
| 392 | IMUX | Immunic, Inc. | 72.77M | -0.72% | 967,476 | - |
| 393 | GANX | Gain Therapeutics, Inc. | 72.69M | -3.57% | 370,451 | - |
| 394 | MREO | Mereo BioPharma Group plc | 70.53M | -1.29% | 2,742,902 | 500.00K |
| 395 | ENTX | Entera Bio Ltd. | 67.87M | 0.68% | 53,028 | 124.00K |
| 396 | KZIA | Kazia Therapeutics Limited | 66.47M | -7.01% | 130,785 | 1.20M |
| 397 | BYSI | BeyondSpring Inc. | 64.15M | 0.65% | 8,256 | 1.88M |
| 398 | NRXP | NRx Pharmaceuticals, Inc. | 62.67M | 0.33% | 612,994 | 242.00K |
| 399 | PMVP | PMV Pharmaceuticals, Inc. | 62.13M | -4.30% | 87,886 | - |
| 400 | IFRX | InflaRx N.V. | 60.94M | -1.25% | 456,015 | 73.73K |
| 401 | ATHE | Alterity Therapeutics Limited | 60.82M | -2.15% | 9,963 | 3.57M |
| 402 | TVGN | Tevogen Bio Holdings Inc. | 59.76M | -6.46% | 372,061 | - |
| 403 | MGX | Metagenomi Therapeutics, Inc. | 59.32M | -1.25% | 181,834 | 30.91M |
| 404 | TCRX | TScan Therapeutics, Inc. | 59.30M | -1.42% | 560,757 | 8.42M |
| 405 | ACRV | Acrivon Therapeutics, Inc. | 58.38M | -2.12% | 396,361 | - |
| 406 | INKT | MiNK Therapeutics, Inc. | 57.50M | -2.31% | 11,598 | - |
| 407 | RADX | Radiopharm Theranostics Limited | 56.98M | -0.30% | 32,813 | 8.20M |
| 408 | NTRB | Nutriband Inc. | 56.61M | -0.92% | 14,711 | 2.28M |
| 409 | ICCC | ImmuCell Corporation | 55.75M | -3.17% | 49,271 | 27.77M |
| 410 | GRCE | Grace Therapeutics, Inc. | 54.24M | -0.14% | 58,382 | - |
| 411 | LPCN | Lipocine Inc. | 50.24M | -4.33% | 54,965 | 4.32M |
| 412 | CVM | CEL-SCI Corporation | 49.70M | -6.19% | 75,857 | - |
| 413 | NRXS | NeurAxis, Inc. | 49.43M | -0.43% | 46,910 | 3.36M |
| 414 | ALGS | Aligos Therapeutics, Inc. | 48.64M | -1.92% | 42,133 | 2.65M |
| 415 | TIL | Instil Bio, Inc. | 48.56M | 0.99% | 36,585 | - |
| 416 | ABVC | ABVC BioPharma, Inc. | 48.56M | 1.52% | 55,941 | 797.92K |
| 417 | CRVO | CervoMed Inc. | 48.48M | -2.96% | 66,091 | 6.16M |
| 418 | IBO | Impact BioMedical Inc. | 48.09M | -0.26% | 122,162 | 25.00K |
| 419 | OSTX | OS Therapies Incorporated | 47.89M | -4.23% | 414,050 | - |
| 420 | QTTB | Q32 Bio Inc. | 47.86M | -1.52% | 150,202 | - |
| 421 | IBIO | iBio, Inc. | 47.67M | -4.93% | 349,425 | 500.00K |
| 422 | PDSB | PDS Biotechnology Corporation | 46.22M | -7.02% | 796,931 | - |
| 423 | ESLA | Estrella Immunopharma, Inc. | 45.82M | 2.83% | 146,261 | - |
| 424 | KZR | Kezar Life Sciences, Inc. | 45.04M | - | 12,904 | - |
| 425 | LITS | Lite Strategy, Inc. | 44.49M | -7.63% | 387,881 | - |
| 426 | JSPR | Jasper Therapeutics, Inc. | 43.37M | -2.52% | 394,669 | - |
| 427 | LONA | LeonaBio, Inc. | 43.23M | -4.54% | 67,812 | - |
| 428 | PSTV | Plus Therapeutics, Inc. | 42.46M | -3.73% | 12,271,763 | 5.26M |
| 429 | INMB | INmune Bio Inc. | 42.00M | -1.86% | 88,197 | 50.00K |
| 430 | TELO | Telomir Pharmaceuticals, Inc. | 41.77M | -3.57% | 162,025 | - |
| 431 | VERU | Veru Inc. | 41.57M | -0.38% | 39,403 | 16.89M |
| 432 | CING | Cingulate Inc. | 40.80M | -3.89% | 184,945 | - |
| 433 | XLO | Xilio Therapeutics, Inc. | 40.70M | -2.44% | 215,894 | 31.80M |
| 434 | LSTA | Lisata Therapeutics, Inc. | 40.66M | 0.66% | 51,786 | 1.07M |
| 435 | GLTO | Galecto, Inc. | 39.73M | 1.74% | 25,475 | - |
| 436 | ATRA | Atara Biotherapeutics, Inc. | 39.58M | -0.18% | 125,415 | 151.93M |
| 437 | SER | Serina Therapeutics, Inc. | 38.18M | 31.62% | 63,360,726 | 116.00K |
| 438 | ATNM | Actinium Pharmaceuticals, Inc. | 38.06M | - | 74,698 | 90.00K |
| 439 | GBIO | Generation Bio Co. | 37.73M | 0.18% | 39,914 | 15.27M |
| 440 | OKUR | OnKure Therapeutics, Inc. | 37.66M | -1.77% | 100,491 | - |
| 441 | APLM | Apollomics, Inc. | 37.64M | -1.75% | 6,349 | 6.93M |
| 442 | RNTX | Rein Therapeutics Inc. | 37.59M | -5.92% | 41,957 | - |
| 443 | NXTC | NextCure, Inc. | 37.40M | -0.28% | 8,156 | - |
| 444 | TVRD | Tvardi Therapeutics, Inc. | 36.68M | -3.69% | 40,965 | - |
| 445 | ANEB | Anebulo Pharmaceuticals, Inc. | 35.42M | 0.83% | 4,090 | - |
| 446 | HOWL | Werewolf Therapeutics, Inc. | 35.35M | 2.07% | 238,523 | 1.14M |
| 447 | CELU | Celularity Inc. | 35.33M | -3.54% | 15,602 | 40.58M |
| 448 | RNXT | RenovoRx, Inc. | 35.18M | 6.55% | 241,382 | 928.00K |
| 449 | PASG | Passage Bio, Inc. | 34.97M | -3.00% | 13,822 | - |
| 450 | LTRN | Lantern Pharma Inc. | 34.45M | -2.84% | 70,771 | - |
| 451 | OTLK | Outlook Therapeutics, Inc. | 34.27M | 3.88% | 1,940,368 | 1.41M |
| 452 | HURA | TuHURA Biosciences, Inc. | 34.22M | -0.84% | 97,290 | - |
| 453 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 34.12M | -0.34% | 1,707,061 | - |
| 454 | KYNB | Kyntra Bio, Inc. | 34.00M | -4.11% | 16,307 | 8.30M |
| 455 | LIXT | Lixte Biotechnology Holdings, Inc. | 33.89M | 4.85% | 208,183 | - |
| 456 | CUE | Cue Biopharma, Inc. | 33.06M | -2.35% | 217,959 | 7.10M |
| 457 | PLUR | Pluri Inc. | 32.93M | -0.60% | 19,311 | 1.33M |
| 458 | DYAI | Dyadic International, Inc. | 32.82M | 3.19% | 35,589 | 3.34M |
| 459 | ANTX | AN2 Therapeutics, Inc. | 32.07M | -1.64% | 4,457 | - |
| 460 | SKYE | Skye Bioscience, Inc. | 31.42M | -2.97% | 160,298 | - |
| 461 | HYPD | Hyperion DeFi, Inc. | 30.99M | -6.11% | 521,068 | 345.32K |
| 462 | RLYB | Rallybio Corporation | 29.80M | 9.81% | 157,717 | 674.00K |
| 463 | BRNS | Barinthus Biotherapeutics plc | 29.80M | -1.08% | 5,788 | 14.97M |
| 464 | GNTA | Genenta Science S.p.A. | 28.59M | -9.63% | 615,989 | - |
| 465 | EVAX | Evaxion A/S | 28.34M | -4.30% | 152,029 | 7.65M |
| 466 | AEON | AEON Biopharma, Inc. | 28.11M | -0.85% | 34,499 | - |
| 467 | BCTX | BriaCell Therapeutics Corp. | 28.09M | -8.12% | 272,969 | - |
| 468 | NRSN | NeuroSense Therapeutics Ltd. | 27.54M | -0.12% | 89,840 | - |
| 469 | PTN | Palatin Technologies, Inc. | 27.04M | -8.20% | 34,878 | 8.85M |
| 470 | DARE | Daré Bioscience, Inc. | 27.01M | -1.56% | 42,674 | -57.13K |
| 471 | MRKR | Marker Therapeutics, Inc. | 26.84M | -1.23% | 181,715 | 4.69M |
| 472 | IGC | IGC Pharma, Inc. | 26.84M | -2.40% | 274,684 | 1.11M |
| 473 | SNTI | Senti Biosciences, Inc. | 26.83M | -0.92% | 201,896 | - |
| 474 | BOLD | Boundless Bio, Inc. | 26.53M | -2.07% | 43,452 | - |
| 475 | XCUR | Exicure, Inc. | 26.50M | -0.77% | 34,747 | 500.00K |
| 476 | PMN | ProMIS Neurosciences, Inc. | 26.14M | 0.54% | 48,261 | - |
| 477 | CLGN | CollPlant Biotechnologies Ltd. | 24.91M | 1.04% | 3,706 | 2.48M |
| 478 | FBLG | FibroBiologics, Inc. | 23.55M | -1.09% | 651,725 | - |
| 479 | IOBT | IO Biotech, Inc. | 23.19M | 3.99% | 933,713 | - |
| 480 | INTS | Intensity Therapeutics, Inc. | 22.22M | -3.12% | 729,381 | - |
| 481 | NNVC | NanoViricides, Inc. | 21.78M | -3.82% | 282,589 | - |
| 482 | NEUP | Neuphoria Therapeutics Inc. | 21.72M | 0.75% | 15,465 | 15.65M |
| 483 | VTGN | Vistagen Therapeutics, Inc. | 21.46M | -7.22% | 1,060,049 | 721.00K |
| 484 | PLRZ | Polyrizon Ltd. | 20.67M | -8.01% | 30,041 | - |
| 485 | JUNS | Jupiter Neurosciences, Inc. | 20.57M | -5.28% | 403,651 | - |
| 486 | CASI | CASI Pharmaceuticals, Inc. | 20.34M | -1.00% | 15,248 | 26.85M |
| 487 | KLTO | Klotho Neurosciences, Inc. | 20.05M | -6.93% | 441,262 | - |
| 488 | INAB | IN8bio, Inc. | 19.78M | 3.32% | 39,900 | - |
| 489 | LNAI | Lunai Bioworks Inc. | 19.41M | 3.68% | 58,731 | - |
| 490 | KTTA | Pasithea Therapeutics Corp. | 19.31M | -1.93% | 102,109 | - |
| 491 | VYNE | VYNE Therapeutics Inc. | 18.88M | 0.41% | 939,635 | 524.00K |
| 492 | QNTM | Quantum BioPharma Ltd. | 18.87M | -0.24% | 39,940 | - |
| 493 | ALLR | Allarity Therapeutics, Inc. | 18.58M | -1.83% | 198,918 | - |
| 494 | LEXX | Lexaria Bioscience Corp. | 18.46M | -2.91% | 45,370 | 522.00K |
| 495 | BCAB | BioAtla, Inc. | 18.09M | -8.18% | 566,025 | 11.00M |
| 496 | CVKD | Cadrenal Therapeutics, Inc. | 17.30M | -3.39% | 34,452 | - |
| 497 | ITRM | Iterum Therapeutics plc | 16.81M | -1.18% | 247,974 | 390.00K |
| 498 | CALC | CalciMedica, Inc. | 16.28M | -9.60% | 4,874,309 | - |
| 499 | LIMN | Liminatus Pharma, Inc. | 16.28M | -1.41% | 80,499 | - |
| 500 | TRAW | Traws Pharma, Inc. | 16.18M | -17.68% | 376,684 | 2.85M |
| 501 | CTXR | Citius Pharmaceuticals, Inc. | 15.88M | -1.95% | 269,166 | - |
| 502 | OSRH | OSR Holdings, Inc. | 15.70M | -1.39% | 661,725 | -90.52K |
| 503 | KALA | KALA BIO, Inc. | 15.05M | -8.06% | 674,206 | - |
| 504 | APLT | Applied Therapeutics, Inc. | 14.56M | 2.36% | 7,075,836 | 1.00M |
| 505 | COCP | Cocrystal Pharma, Inc. | 14.20M | 0.98% | 83,834 | - |
| 506 | HOTH | Hoth Therapeutics, Inc. | 14.05M | -5.88% | 249,495 | - |
| 507 | CLRB | Cellectar Biosciences, Inc. | 13.89M | -1.06% | 23,677 | - |
| 508 | KAPA | Kairos Pharma, Ltd. | 13.52M | -3.78% | 91,546 | - |
| 509 | SNGX | Soligenix, Inc. | 13.46M | -2.55% | 195,352 | 2.34K |
| 510 | BCDA | BioCardia, Inc. | 13.11M | -5.00% | 62,490 | 3.00K |
| 511 | MBRX | Moleculin Biotech, Inc. | 12.99M | -8.06% | 52,096 | - |
| 512 | BLRX | BioLineRx Ltd. | 12.63M | 4.65% | 6,132 | 12.74M |
| 513 | TPST | Tempest Therapeutics, Inc. | 12.61M | -8.24% | 58,825 | - |
| 514 | SNSE | Sensei Biotherapeutics, Inc. | 12.35M | -2.83% | 29,135 | - |
| 515 | BOLT | Bolt Biotherapeutics, Inc. | 12.27M | -4.77% | 28,273 | 5.20M |
| 516 | LGVN | Longeveron Inc. | 11.95M | -5.74% | 177,943 | 1.44M |
| 517 | CRIS | Curis, Inc. | 11.83M | -0.12% | 87,828 | 11.65M |
| 518 | NCEL | NewcelX Ltd. | 11.81M | -1.89% | 186,653 | - |
| 519 | IMNN | Imunon, Inc. | 11.56M | - | 15,447 | - |
| 520 | NCNA | NuCana plc | 11.32M | -7.80% | 126,522 | - |
| 521 | PHGE | BiomX Inc. | 11.10M | 10.49% | 925,750 | - |
| 522 | PHIO | Phio Pharmaceuticals Corp. | 10.93M | -0.49% | 158,790 | - |
| 523 | EDSA | Edesa Biotech, Inc. | 10.79M | -3.36% | 179,611 | - |
| 524 | AKTX | Akari Therapeutics, Plc | 10.68M | -8.13% | 564,868 | - |
| 525 | GRDX | GridAI Technologies Corp. | 10.04M | -0.50% | 71,717 | - |
| 526 | CMMB | Chemomab Therapeutics Ltd. | 10.03M | 0.62% | 32,657 | - |
| 527 | BRTX | BioRestorative Therapies, Inc. | 10.01M | -1.07% | 5,088 | 383.40K |
| 528 | RNAZ | TransCode Therapeutics, Inc. | 9.54M | -6.18% | 12,915 | - |
| 529 | EVGN | Evogene Ltd. | 9.51M | -4.72% | 27,050 | 8.02M |
| 530 | ERNA | Ernexa Therapeutics Inc. | 9.50M | -2.43% | 11,583 | 1,000.00 |
| 531 | PULM | Pulmatrix, Inc. | 9.50M | -2.63% | 4,240 | 3.00K |
| 532 | BIVI | BioVie Inc. | 9.27M | - | 38,645 | - |
| 533 | GDTC | CytoMed Therapeutics Limited | 9.06M | -4.80% | 24,882 | 573.19K |
| 534 | REVB | Revelation Biosciences, Inc. | 8.78M | -11.48% | 684,411 | - |
| 535 | KPRX | Kiora Pharmaceuticals, Inc. | 8.41M | 7.17% | 454,306 | 20.00K |
| 536 | ICU | SeaStar Medical Holding Corporation | 8.38M | -2.74% | 78,356 | 881.00K |
| 537 | PMCB | PharmaCyte Biotech, Inc. | 8.37M | -8.17% | 277,879 | - |
| 538 | XTLB | XTL Biopharmaceuticals Ltd. | 8.24M | -6.28% | 76,168 | 968.00K |
| 539 | ADXN | Addex Therapeutics Ltd | 8.23M | 5.91% | 4,648 | 198.82K |
| 540 | IMRN | Immuron Limited | 7.96M | -2.79% | 11,227 | 4.78M |
| 541 | CLDI | Calidi Biotherapeutics, Inc. | 7.68M | 1.94% | 35,709 | - |
| 542 | ALZN | Alzamend Neuro, Inc. | 7.68M | -6.45% | 66,350 | - |
| 543 | MTVA | MetaVia Inc. | 7.54M | 0.43% | 54,709 | - |
| 544 | GTBP | GT Biopharma, Inc. | 7.36M | -4.13% | 629,978 | - |
| 545 | MBIO | Mustang Bio, Inc. | 7.17M | -2.75% | 73,874 | - |
| 546 | CELZ | Creative Medical Technology Holdings, Inc. | 7.15M | -2.11% | 21,848 | 6.00K |
| 547 | PCSA | Processa Pharmaceuticals, Inc. | 7.14M | 0.32% | 14,839 | - |
| 548 | APVO | Aptevo Therapeutics Inc. | 7.12M | -8.87% | 85,765 | - |
| 549 | QNRX | Quoin Pharmaceuticals, Ltd. | 7.10M | -7.03% | 44,346 | - |
| 550 | TOVX | Theriva Biologics, Inc. | 6.69M | -1.83% | 1,223,984 | - |
| 551 | APM | Aptorum Group Limited | 6.63M | -4.25% | 56,881 | - |
| 552 | PPBT | Purple Biotech Ltd | 6.59M | -2.43% | 122,764 | - |
| 553 | SLXN | Silexion Therapeutics Corp | 6.22M | -2.45% | 47,138 | - |
| 554 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 6.17M | -7.79% | 167,047 | 1.36M |
| 555 | TCRT | Alaunos Therapeutics, Inc. | 6.05M | -2.34% | 5,595 | 6.00K |
| 556 | BGMS | Bio Green Med Solution, Inc. | 6.03M | -0.81% | 6,409 | 81.00K |
| 557 | ADIL | Adial Pharmaceuticals, Inc. | 6.02M | -1.55% | 172,023 | - |
| 558 | CANF | Can-Fite BioPharma Ltd. | 5.95M | -4.74% | 16,296 | 560.00K |
| 559 | ACXP | Acurx Pharmaceuticals, Inc. | 5.91M | -2.84% | 47,734 | - |
| 560 | GNPX | Genprex, Inc. | 5.77M | 12.16% | 5,697,042 | - |
| 561 | XBIO | Xenetic Biosciences, Inc. | 5.45M | -4.44% | 16,257 | 2.86M |
| 562 | ABP | Abpro Holdings, Inc. | 5.41M | -15.32% | 57,562 | 183.00K |
| 563 | DCOY | Decoy Therapeutics Inc. | 5.30M | -3.91% | 93,347 | - |
| 564 | CYCN | Cyclerion Therapeutics, Inc. | 5.21M | -5.51% | 53,765 | 2.86M |
| 565 | INDP | Indaptus Therapeutics, Inc. | 5.06M | -1.53% | 18,051 | - |
| 566 | PBM | Psyence Biomedical Ltd. | 4.92M | 0.01% | 165,056 | - |
| 567 | GOVX | GeoVax Labs, Inc. | 4.79M | -1.76% | 58,110 | 3.35M |
| 568 | MLEC | Moolec Science SA | 4.73M | -1.51% | 9,337 | 7.83M |
| 569 | SILO | Silo Pharma, Inc. | 4.65M | -4.30% | 60,153 | 72.10K |
| 570 | VIVS | VivoSim Labs, Inc. | 4.54M | 0.58% | 8,922 | 140.00K |
| 571 | MTNB | Matinas BioPharma Holdings, Inc. | 4.21M | -3.38% | 65,142 | - |
| 572 | GLMD | Galmed Pharmaceuticals Ltd. | 4.14M | -6.83% | 86,157 | - |
| 573 | APRE | Aprea Therapeutics, Inc. | 4.06M | -24.04% | 5,366,984 | 488.24K |
| 574 | ASBP | Aspire Biopharma Holdings, Inc. | 4.02M | -5.97% | 4,555,603 | 1.94K |
| 575 | ELAB | PMGC Holdings Inc. | 4.01M | -0.61% | 123,787 | 285.95K |
| 576 | PPCB | Propanc Biopharma, Inc. | 3.79M | -27.21% | 1,586,997 | - |
| 577 | XRTX | XORTX Therapeutics Inc. | 3.74M | -4.87% | 44,654 | - |
| 578 | CNSP | CNS Pharmaceuticals, Inc. | 3.64M | 0.77% | 11,026 | - |
| 579 | LYRA | Lyra Therapeutics, Inc. | 3.57M | -1.95% | 63,773 | 600.00K |
| 580 | ARTL | Artelo Biosciences, Inc. | 3.52M | -3.59% | 22,641 | - |
| 581 | OGEN | Oragenics, Inc. | 3.43M | -1.53% | 132,104 | - |
| 582 | SPRC | SciSparc Ltd. | 3.39M | -6.64% | 264,788 | 1.31M |
| 583 | CMND | Clearmind Medicine Inc. | 3.34M | -11.68% | 50,224 | - |
| 584 | DRMA | Dermata Therapeutics, Inc. | 3.29M | 11.11% | 1,422,042 | - |
| 585 | SCNI | Scinai Immunotherapeutics Ltd. | 3.26M | -8.74% | 34,500 | 1.15M |
| 586 | ENVB | Enveric Biosciences, Inc. | 3.18M | -11.03% | 189,589 | - |
| 587 | HCWB | HCW Biologics Inc. | 3.11M | -5.74% | 43,172 | 422.03K |
| 588 | JAGX | Jaguar Health, Inc. | 3.10M | 1.18% | 457,542 | 11.79M |
| 589 | BBLG | Bone Biologics Corporation | 3.05M | 0.59% | 5,923 | - |
| 590 | CDIO | Cardio Diagnostics Holdings, Inc. | 2.89M | -11.24% | 184,013 | 15.78K |
| 591 | AZTR | Azitra, Inc. | 2.86M | -3.75% | 1,010,650 | 7.50K |
| 592 | ENSC | Ensysce Biosciences, Inc. | 2.63M | -7.99% | 144,694 | 4.49M |
| 593 | ONCO | Onconetix, Inc. | 2.35M | 0.67% | 8,666 | 1.22M |
| 594 | VRAX | Virax Biolabs Group Limited | 2.03M | -5.56% | 183,890 | 2.99K |
| 595 | CDT | CDT Equity Inc. | 1.98M | - | 43,556 | - |
| 596 | GRI | GRI Bio, Inc. | 1.82M | -17.52% | 465,323 | - |
| 597 | BDRX | Biodexa Pharmaceuticals Plc | 1.55M | -11.06% | 147,133 | 104.90K |
| 598 | ADTX | Aditxt, Inc. | 1.44M | -11.65% | 324,136 | 5.95K |